Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis

Journal of Clinical Gastroenterology

Volumn 42, Issue 8, 2008, Pages 926-930

  Lüth, Stefan ^a   Herkel, Johannes ^a   Kanzler, Stephan ^b   Frenzel, Christian ^a   Galle, Peter R ^b   Dienes, Hans P ^c   Schramm, Christoph ^a   Lohse, Ansgar W ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Disease management; Follow up; Immunosuppression; Individualized therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GAMMA GLOBIN; IMMUNOGLOBULIN G; PREDNISOLONE; BIOLOGICAL MARKER;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; BLOOD SAMPLING; CLINICAL PRACTICE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DISEASE MARKER; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; RISK; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEROLOGY; BIOPSY; BLOOD; DISEASE COURSE; IMMUNOLOGY; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TEST; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BIOPSY; DISEASE PROGRESSION; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN G; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED;

EID: 54549127081     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318154af74     Document Type: Article

References (20)

1. Geall MG, Schoenfield LJ, Summerskill WHJ. Classification and treatment of chronic active liver disease. Gastroenterology. 1968; 55:724-729.
2. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology. 1996; 110:848-857.
3. Kanzler S, Lohr H, Gerken G, et al. Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience. Z Gastroenterol. 2001;39:339-348.
4. Heneghan MA, McFarlane IG. Current and novel immunosup-pressive therapy for autoimmune hepatitis. Hepatology. 2002;35: 7-13.
5. Czaja AJ, Freese DK. Diagnosis and treatment of autoimmune hepatitis. Hepatology. 2002;36:479-497.
6. Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med. 1993; 118:96-98.
7. Lindor KD, Bru C, Jorgensen RA, et al. The role of ultrasono-graphy and automatic needle biopsy in outpatient percutaneous liver biopsy. Hepatology. 1996;23:1079-1083.
8. Thampanitchwong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gastroenterol. 1999;5:301-304.
9. Czaja AJ, Wolf AM, Baggenstoss AH. Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features. Gastroenterology. 1981;80: 687-692.
10. Miyake Y, Iwasaki Y, Terada R, et al. Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis. J Hepatol. 2005;43:951-957.
11. Verma S. In type 1 autoimmune hepatitis (AIH), should remission be redefined as normalization of transaminases? J Hepatol. 2006; 44:819-820.
12. Meyer zum Buschenfelde KH, Lohse AW. Autoimmune Hepatitis. N Engl J Med. 1995;333:1004-1005.
13. World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997;277:925-926.
14. Menghini G. One-second needle biopsy of the liver. Gastroenterol-ogy. 1958;35:190-199.
15. Helmreich-Becker I, Meyer zum Buschenfelde KH, Lohse AW. Safety and feasibility of a new minimally invasive diagnostic laparoscopy technique. Endoscopy. 1998;30:756-762.
16. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
17. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19: 1513-1520.
18. Sanchez-Urdazpal L, Czaja AJ, van Hoek B, et al. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology. 1992;15:215-221.
19. Bayer E, Herr W, Kanzler S, et al. Transforming growth factor-b1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J Hepatol. 1998;28:803-811.
20. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology. 1996; 110:848-857.